Biotech Funding
When a private company raises money from investors without selling shares on a stock exchange, it files a short notice with the SEC called a Form D. These are the notices from biotech, drug and other health-care companies.
20,780 private offerings by biotech, pharma and other health-care companies, from the Form D notices they filed with the SEC from 2016 to Nov 12, 2026. One row per offering; an amended notice updates the amount sold.
- Raises in the last 12 months: 1,555
- Sold in the last 12 months: $13.2B
- Biotech share: 41%
Raises per Year
New Form D offerings; 2026 to Nov 12, 2026.
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
- Full year
- 2026 to date
Dollars Sold per Year
What companies reported selling, by the year the offering was first filed. Large rounds dominate.
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
- Full year
- 2026 to date
Largest Raises in the Last 12 Months
By amount sold; each amount opens the filing on EDGAR.| Entera Bio Ltd. | Biotech | $275M | $275M | Israel | Aug 12, 2026 |
| Precision Neuroscience | Other health care | $250M | Open-ended | NY | Sep 28, 2026 |
| Zai Lab Ltd | Biotech | $250M | $250M | MA | Nov 9, 2026 |
| AdvanCell, Inc. | Biotech | $218M | $315M | MA | Jul 16, 2026 |
| Odyssey Therapeutics, Inc. | Biotech | $214M | $214M | MA | Dec 4, 2025 |
| Immunic, Inc. | Biotech | $200M | $200M | United States | Mar 4, 2026 |
| Epicrispr Biotechnologies, Inc. | Biotech | $177M | $213M | CA | Aug 26, 2026 |
| Ollin Biosciences, Inc. | Biotech | $156M | $330M | TX | Jun 24, 2026 |
| Rightway Healthcare, Inc. | Other health care | $155M | $155M | NY | Sep 8, 2026 |
| Curative, LLC | Health insurance | $153M | $200M | TX | Dec 4, 2025 |
| Jasper Therapeutics, Inc. | Biotech | $132M | $132M | CA | Aug 5, 2026 |
| CP Venture IV, LP | Other health care | $126M | Open-ended | WA | Dec 19, 2025 |
| SonoThera, Inc. | Biotech | $125M | $125M | CA | Jun 30, 2026 |
| Solstice Oncology, Inc. | Biotech | $121M | $298M | MA | Mar 9, 2026 |
| Triana Biomedicines, Inc. | Pharma | $120M | $120M | MA | Dec 4, 2025 |
| Pelage Pharmaceuticals, Inc. | Pharma | $120M | $120M | CA | Nov 24, 2025 |
| Iliad Biotechnologies, Inc. | Biotech | $116M | $116M | FL | Feb 20, 2026 |
| Quince Therapeutics, Inc. | Biotech | $115M | $186M | CA | Jun 11, 2026 |
| Rakuten Medical, Inc. | Biotech | $112M | $117M | CA | Apr 13, 2026 |
| Imperative Care | Other health care | $111M | $111M | CA | Mar 20, 2026 |
| Climb Bio, Inc. | Biotech | $110M | $110M | MA | May 4, 2026 |
| Strand Therapeutics Inc. | Biotech | $108M | $120M | MA | Mar 17, 2026 |
| Candid Group, Inc. | Other health care | $105M | Open-ended | CA | Jul 22, 2026 |
| Iambic Therapeutics, Inc. | Biotech | $99.3M | $125M | CA | Nov 21, 2025 |
| American Republic Insurance Co | Health insurance | $95.0M | $95.0M | IA | Oct 22, 2026 |
Newest Filings
Form D notices filed in the last weeks, newest first. A notice can come before any money is sold.| Orcosa Inc. | Biotech | $6.0M | $11.5M | NJ | Nov 12, 2026 |
| Care Nimble, Inc. | Other health care | $275K | $1.5M | DE | Nov 12, 2026 |
| Lithe Medical, Inc. | Other health care | $100K | $350K | MA | Nov 12, 2026 |
| Tiger Diagnostics Laboratory, Inc. | Other health care | $100K | $1.5M | SC | Nov 12, 2026 |
| Ventoux Biosciences, Inc | Biotech | $95K | $95K | CA | Nov 12, 2026 |
| Mercury Bio, Inc. | Biotech | $13K | $13K | NM | Nov 12, 2026 |
| Endoscopy Center at Saint Mary Management, LLC | Other health care | None yet | $2K | PA | Nov 12, 2026 |
| Surgicare Of La Veta Ltd | Other health care | None yet | $432K | CA | Nov 12, 2026 |
| AngioInsight, Inc. | Other health care | $16.3M | $20.0M | MN | Nov 10, 2026 |
| Abvc Biopharma, Inc. | Biotech | $3.4M | $3.4M | CA | Nov 10, 2026 |
| Bloodless Diagnostics Inc. | Other health care | $1.3M | $2.5M | NC | Nov 10, 2026 |
| Chickadee Biomedicines, Inc. | Biotech | $1.0M | $1.0M | NY | Nov 10, 2026 |
| Drizzle Health, LLC | Biotech | $600K | Open-ended | MD | Nov 10, 2026 |
| SUTOL BIO, Inc. | Biotech | $474K | $474K | MA | Nov 10, 2026 |
| Frontier Bio Corp | Biotech | $380K | $1.0M | CA | Nov 10, 2026 |
| Zai Lab Ltd | Biotech | $250M | $250M | MA | Nov 9, 2026 |
| Transformer TX Holdings, LLC | Hospitals and physicians | $4.1M | $319M | TX | Nov 9, 2026 |
| NBO Pharma Inc. | Pharma | $238K | $7.0M | NY | Nov 9, 2026 |
| Luminoah | Other health care | $25.4M | $25.4M | VA | Nov 6, 2026 |
| Hawkeye Group, LLC /In/ | Other health care | $1.6M | $3.5M | IN | Nov 6, 2026 |
| GiftWellSoon, LLC | Other health care | $75K | $500K | DE | Nov 6, 2026 |
| Helande Innovations, Inc. | Other health care | $50K | $50K | CA | Nov 6, 2026 |
| BridgeHealth Pharmaceuticals, Inc. | Pharma | $3.5M | $3.5M | MA | Nov 5, 2026 |
| Ictero Medical, Inc. | Other health care | $344K | $696K | TX | Nov 5, 2026 |
| GOA Therapeutics Corp | Pharma | $300K | $225M | FL | Nov 5, 2026 |
| Helande Innovations, Inc. | Other health care | $70K | $1.0M | CA | Nov 5, 2026 |
| Conexeu Sciences Inc. | Biotech | $22K | $22K | NV | Nov 5, 2026 |
| Conexeu Sciences Inc. | Biotech | $5K | $5K | NV | Nov 5, 2026 |
| Treasure Valley Hospital Limited Partnership | Other health care | None yet | $3.1M | ID | Nov 5, 2026 |
| Traws Pharma, Inc. | Biotech | None yet | $50.0M | PA | Nov 5, 2026 |
| Nocionix,Inc. | Other health care | $2.7M | $10.0M | OH | Nov 4, 2026 |
| LadyBits, Inc. | Other health care | $320K | $807K | VA | Nov 4, 2026 |
| Allina Health Surgery Center - Brooklyn Park, LLC | Other health care | $135K | $585K | MN | Nov 4, 2026 |
| Ausel, Inc. | Biotech | $120K | $5.0M | CA | Nov 4, 2026 |
| BlueHealer Inc. | Biotech | $1 | $1 | MD | Nov 4, 2026 |
| PulsePoint Lake Norman ASC, LLC | Other health care | None yet | $1.8M | FL | Nov 4, 2026 |
| EVIA Life Sciences Inc. | Biotech | $700K | $5.5M | Japan | Nov 2, 2026 |
| Advocate Southwest Ambulatory Surgery Center, L.L.C. | Other health care | None yet | $189K | IL | Nov 2, 2026 |
| Teos Health, LLC | Other health care | $3.1M | $3.1M | TX | Oct 30, 2026 |
| Tru Singular Health, Inc. | Biotech | $1.0M | $1.0M | MA | Oct 30, 2026 |
| 511 Therapeutics, Inc. | Biotech | $500K | $1.0M | MA | Oct 30, 2026 |
| ChemoMouthpiece, LLC | Other health care | $400K | $10.0M | DE | Oct 30, 2026 |
| Palimpsest Bio Corp. | Biotech | $172K | $1.0M | NV | Oct 30, 2026 |
| Synomis, Inc. | Biotech | $30K | $2.5M | TN | Oct 30, 2026 |
| Swep Bio, Inc. | Biotech | $2.5M | $5.0M | NY | Oct 29, 2026 |
| SymKardia, Inc. | Other health care | $4.0M | $4.0M | OH | Oct 28, 2026 |
| PCFM Investments, LLC | Hospitals and physicians | $2.0M | $2.1M | KY | Oct 28, 2026 |
| Accufy Diagnostics, Inc. | Biotech | $2.0M | $2.0M | MD | Oct 28, 2026 |
| FIMA Investments, LLC | Hospitals and physicians | None yet | $930K | KY | Oct 28, 2026 |
| Oncology AI Fleet, Inc. | Other health care | None yet | $500K | DE | Oct 28, 2026 |
A private company that sells securities under Regulation D must file a Form D within 15 days of its first sale. It lists the amount offered and sold so far, not who invested or at what valuation, and some companies never file. Included: issuers whose industry group is biotechnology, pharmaceuticals, other health care, hospitals and physicians, or health insurance; pooled investment funds are not. Completed quarters come from SEC's quarterly data sets and the current quarter from EDGAR's daily index. Refreshed weekly. SEC Form D data sets and EDGAR · Updated Nov 13, 2026